SALVIA, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 27.065
EU - Europa 25.417
AS - Asia 18.413
SA - Sud America 2.585
Continente sconosciuto - Info sul continente non disponibili 801
AF - Africa 614
OC - Oceania 60
AN - Antartide 1
Totale 74.956
Nazione #
US - Stati Uniti d'America 26.368
RU - Federazione Russa 10.118
SG - Singapore 7.380
CN - Cina 5.229
GB - Regno Unito 4.695
IT - Italia 3.140
BR - Brasile 2.076
HK - Hong Kong 1.613
VN - Vietnam 1.575
DE - Germania 1.494
SE - Svezia 1.292
FR - Francia 1.210
IE - Irlanda 1.112
FI - Finlandia 795
KR - Corea 544
BD - Bangladesh 504
CA - Canada 388
NL - Olanda 323
IN - India 318
UA - Ucraina 270
JP - Giappone 267
AR - Argentina 192
ES - Italia 186
MX - Messico 185
TR - Turchia 170
NG - Nigeria 134
PL - Polonia 133
ID - Indonesia 130
AT - Austria 123
ZA - Sudafrica 122
IQ - Iraq 113
BE - Belgio 88
CZ - Repubblica Ceca 81
TG - Togo 78
PK - Pakistan 77
BJ - Benin 62
EC - Ecuador 61
CO - Colombia 60
LT - Lituania 56
MA - Marocco 56
UZ - Uzbekistan 55
VE - Venezuela 54
AU - Australia 49
PH - Filippine 42
CL - Cile 41
SA - Arabia Saudita 41
AE - Emirati Arabi Uniti 39
JO - Giordania 39
PY - Paraguay 39
CH - Svizzera 37
EG - Egitto 35
NP - Nepal 33
KE - Kenya 31
RO - Romania 30
TN - Tunisia 30
IL - Israele 29
IR - Iran 27
PE - Perù 27
AZ - Azerbaigian 26
JM - Giamaica 24
KG - Kirghizistan 21
PT - Portogallo 21
AL - Albania 20
LV - Lettonia 19
DZ - Algeria 18
SI - Slovenia 18
CR - Costa Rica 17
HU - Ungheria 17
KZ - Kazakistan 17
MY - Malesia 17
RS - Serbia 17
GR - Grecia 16
UY - Uruguay 16
HR - Croazia 15
BO - Bolivia 14
BG - Bulgaria 13
LB - Libano 13
OM - Oman 13
GT - Guatemala 12
NO - Norvegia 12
DK - Danimarca 11
HN - Honduras 11
PA - Panama 11
TH - Thailandia 10
DO - Repubblica Dominicana 9
LU - Lussemburgo 9
SK - Slovacchia (Repubblica Slovacca) 9
TT - Trinidad e Tobago 9
BY - Bielorussia 8
ET - Etiopia 8
EU - Europa 8
PS - Palestinian Territory 8
AM - Armenia 7
BA - Bosnia-Erzegovina 7
EE - Estonia 7
PR - Porto Rico 7
SY - Repubblica araba siriana 7
BB - Barbados 6
BH - Bahrain 6
GA - Gabon 6
Totale 74.036
Città #
Singapore 3.964
Southend 3.902
Moscow 3.675
Ashburn 3.194
Dallas 3.162
San Jose 2.618
Chandler 2.454
Hong Kong 1.588
Jacksonville 1.385
Verona 1.243
Dublin 1.081
Woodbridge 1.070
The Dalles 922
Beijing 900
New York 687
Ann Arbor 647
Houston 611
Council Bluffs 591
Ho Chi Minh City 530
Los Angeles 523
Munich 456
Lawrence 374
Princeton 374
Wilmington 355
Jinan 350
Hanoi 346
Nanjing 293
Santa Clara 277
Helsinki 255
Shenyang 255
Buffalo 239
Tokyo 231
São Paulo 224
Milan 211
Redondo Beach 189
Sindelfingen 185
Orem 178
Redmond 177
Tianjin 175
Hebei 170
Columbus 164
London 159
Turku 143
Montreal 136
Hangzhou 131
Haikou 127
Seattle 125
Abuja 121
Zhengzhou 120
Rome 119
Warsaw 114
Frankfurt am Main 110
Amsterdam 108
Ningbo 108
Toronto 106
Denver 104
Stockholm 103
Changsha 100
Chennai 100
Guangzhou 98
Taiyuan 95
Brooklyn 92
Atlanta 90
Nanchang 89
San Francisco 86
Taizhou 85
Boardman 84
Brussels 84
Chicago 82
Rio de Janeiro 81
Johannesburg 80
Lancaster 79
Bologna 78
Lomé 78
Da Nang 77
Nuremberg 75
Jiaxing 74
Phoenix 72
Fairfield 71
Poplar 71
Seoul 70
Falkenstein 68
Lappeenranta 67
Mexico City 67
Haiphong 66
Jakarta 66
Vienna 65
Washington 65
Belo Horizonte 63
Cotonou 62
Mumbai 52
Redwood City 52
Brno 51
Manchester 50
Paris 50
Fuzhou 47
Tashkent 47
Norwalk 46
Falls Church 45
Kent 43
Totale 45.222
Nome #
Supplemental parenteral nutrition within an enhanced recovery program for open pancreatoduodenectomy for cancer: a pragmatic, multicenter, randomized controlled trial 394
Assessment of Psychological Burden in Individuals with Hereditary Risk of Pancreatic Cancer Under Surveillance: Evaluation of Distress 3 Years After Enrollment 341
Somatostatin analogs for resectable pancreatic neuroendocrine tumors in high-risk surgical patients: Data from a single-center cohort 298
Resezione intermedia e pancreasectomia distale per neoplasie benigne del pancreas: confronto per complicanze postoperatorie e costi 286
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 267
Genomic characterization of hepatoid tumors: context matters 261
Branch duct IPMTs: value of cross-sectional imaging in the assessment of biological behavior and follow-up. 256
Genomic analyses identify molecular subtypes of pancreatic cancer 256
(Intraductal papillary mucinous tumors) Clinical manifestations and therapeutic management. 255
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas 254
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 252
Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma 251
Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations 248
Alcohol and smoking as risk factors in chronic pancreatitits and pancreatic cancer 246
A Single Institution's 27-Year Surgical Experience with Pancreatic Neuroendocrine Tumors: Time Trends, Comparison of Current Staging Systems and Outcome Analysis 245
"Paraduodenal" pancreatitis: results of surgery on 58 consecutives patients from a single institution. 244
Amylase value in drains after pancreatic resection as predictive factor of postoperative pancreatic fistula: results of a prospective study in 137 patients. 242
Gα15 in early onset of pancreatic ductal adenocarcinoma 242
Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity? Results from a Single-Center Surgical Series 241
Central pancreatectomy for benign or low-grade malignant pancreatic lesions - A single-center retrospective analysis of 116 cases 239
Association between macroscopically visible tissue samples and diagnostic accuracy of EUS-guided through-the-needle microforceps biopsy sampling of pancreatic cystic lesions 239
[Closed surgical treatment in acute severe pancreatitis] 236
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution. 236
Differences between main-duct and branch-duct intraductal papillary mucinous neoplasms of the pancreas 234
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 233
A root-cause analysis of mortality following major pancreatectomy 230
Acoustic radiation force impulse (ARFI) ultrasound imaging of pancreatic cystic lesions 227
"Trivial" Cysts Redefine the Risk of Cancer in Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Potential Target for Follow-Up Discontinuation? 227
A case of intraductal papillary mucinous tumour following recurrent attacks of pancreatitis lasting 26 years 223
Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center 221
Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors 221
A multimodality test to guide the management of patients with a pancreatic cyst 221
A case of intraductal papillary mucinous tumour following recurrent attacks of pancreatitis lasting 26 years. 220
Observational study of the incidence of pancreatic and extrapancreatic malignancies during surveillance of patients with branch-duct intraductal papillary mucinous neoplasm 220
A prospective non-randomised single-center study comparing laparoscopic and robotic distal pancreatectomy 220
Decoding Grade B Pancreatic Fistula: A Clinical and Economical Analysis and Subclassification Proposal 219
Antibiotic Prophylaxis with Piperacillin-Tazobactam Reduces Post-Operative Infectious Complication after Pancreatic Surgery: An Interventional, Non-Randomized Study 218
"Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms 217
11-6: CONTINUOUS GLUCOSE MONITORING AND ASSESSMENT OF LONG-TERM ISLET FUNCTION IN AUTOLOGOUS ISLET TRANSPLANTATION AFTER TOTAL PANCREATECTOMY FOR PANCREATIC NEOPLASIA: PRELIMINARY DATA FROM THE VERONA COHORT 216
Is there a role for near-infrared technology in laparoscopic resection of pancreatic neuroendocrine tumors? Results of the COLPAN "colour-and-resect the pancreas" study 216
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 215
Combined modality treatment for patients with locally advanced pancreatic adenocarcinoma 214
Expression of inducible nitric oxide synthase and cyclooxygenase-2 in human pancreas 213
Radiofrequency ablation for locally advanced pancreatic cancer: SMAD4 analysis segregates a responsive subgroup of patients 213
Pancreatic Enucleation Patients Share the Same Quality of Life as the General Population at Long-Term Follow-Up: A Propensity-Score Matched Analysis 212
Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate? Results of a prospective protocol on the management of 109 consecutive patients. 211
Triple approach strategy for patients with locally advanced pancreatic carcinoma 211
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts 210
Reinforced stapler versus ultrasonic dissector for pancreatic transection and stump closure for distal pancreatectomy: A propensity matched analysis 210
An Overview of Artificial Intelligence Applications in Liver and Pancreatic Imaging 210
Distal Pancreatectomy Fistula Risk Score (D-FRS): Development and International Validation 209
Delaying surgery for patients with a previous SARS-CoV-2 infection 206
Gemcitabine-based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score-matched cohort study 205
A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma 205
Sex differences in oncogenic mutational processes 204
Beyond Pancreatic Cyst Epithelium: Evidence of Ovarian-Like Stroma in EUS-Guided Through-the-Needle Micro-Forceps Biopsy Specimens 203
Acinar Cystic Transformation of the Pancreas: Histomorphology and Molecular Analysis to Unravel its Heterogeneous Nature 200
Bioethics in an oncological surgery unit during the COVID-19 pandemic: the Verona experience 200
Local Ablative Strategies for Ductal Pancreatic Cancer (Radiofrequency Ablation, Irreversible Electroporation): A Review 197
MR imaging and MR cholangiopancreatography of multifocal intraductal papillary mucinous neoplasms of the side branches: MR pattern and its evolution(Article) [Risonanza magnetica (RM) e colangiopancreatografia con RM (CPRM) dei tumori intraduttali papillari mucino-secernenti (TIPM) multifocali dei dotti pancreatici secondari: Semeiotica ed evoluzione] 196
Preoperative surveillance rectal swab is associated with an increased risk of infectious complications in pancreaticoduodenectomy and directs antimicrobial prophylaxis: an antibiotic stewardship strategy? 196
Clinical Implications of the 2016 International Study Group on Pancreatic Surgery Definition and Grading of Postoperative Pancreatic Fistula on 775 Consecutive Pancreatic Resections 195
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns 194
Pancreatic Hepatoid Carcinoma: A Review of the Literature 194
Oncocytic Intraductal Papillary Mucinous Neoplasms of the Pancreas: Imaging and Histopathological Findings 194
Cost-effectiveness and quality of life analysis of laparoscopic and robotic distal pancreatectomy: a propensity score-matched study 194
Dual-tracer (68Ga-DOTATOC and 18F-FDG-)-PET/CT scan and G1-G2 non-functioning pancreatic neuroendocrine tumors: A single-center retrospective evaluation of 124 non-metastatic resected cases 194
Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment 193
Obstructive chronic pancreatitis and/or intraductal papillary mucinous neoplasms (IPMNs): a 21-year long case report. 192
Role of unlabelled somatostatin analogues in the prevention of complications after elective pancreatic and peripancreatic surgery: a critical review 192
FAM49B, a novel regulator of mitochondrial function and integrity that suppresses tumor metastasis 192
Anastomotic leakage in pancreatic surgery. 191
Biliary fistula after pancreaticoduodenectomy: data from 1618 consecutive pancreaticoduodenectomies 191
A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer 191
Anastomotic leakage in pancreatic surgery. 190
Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. 190
Amylase value in drains after pancreatic resection as predictive factor of postoperative pancreatic fistula - Results of a prospective study in 137 patients 189
Erratum to: Branch duct IPMTs: value of cross-sectional imaging in the assessment of biological behavior and follow-up 189
Clinical and biological behavior of pancreatic solid pseudopapillary tumors: report on 31 consecutive patients. 189
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 188
Anastomotic leakeage in pancreatic surgery 188
Reconstruction by pancreaticojejunostomy versus pancreaticogastrostomy following pancreatectomy: results of a comparative study. 188
Ablation treatments in unresectable pancreatic cancer 188
CD117 Is a Specific Marker of Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas, Oncocytic Subtype 188
Laparoscopic distal pancreatectomy: analysis of trends in surgical techniques, patient selection, and outcomes 187
Results of 100 pancreatic radiofrequency ablations in the context of a multimodal strategy for stage III ductal adenocarcinoma 186
A dynamic analysis of empirical survival outcomes after pancreatectomy for pancreatic ductal adenocarcinoma 185
Results of a surveillance protocol for pancreatic BD-IPMNs 185
Chyle leak after pancreatic surgery: validation of the International Study Group of Pancreatic Surgery classification 185
Palliative therapy in pancreatic cancer-interventional treatment with radiofrequency ablation/irreversible electroporation 185
Risk Adapted Ablative Radiotherapy After Intensive Chemotherapy for Locally Advanced Pancreatic Cancer 185
Enucleation of pancreatic neoplasms. 184
Pancreaticoduodenectomy for distal cholangiocarcinoma: surgical results, prognostic factors, and long-term follow-up 184
Prophylaxis for septic complications in acute necrotizing pancreatitis 182
Incidence of cancer in the course of chronic pancreatitis 182
An unforeseeable adverse event during ERCP 182
Branch Duct IPMN-Associated Acute Pancreatitis in a Large Single-Center Cohort Study 181
Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration 181
Mucinous cystic neoplasms and serous cystadenomas arising in the body-tail of the pancreas: MR imaging characterization 180
A randomized controlled trial of stapled versus ultrasonic transection in distal pancreatectomy 180
Totale 21.480
Categoria #
all - tutte 260.623
article - articoli 250.983
book - libri 0
conference - conferenze 3.844
curatela - curatele 0
other - altro 391
patent - brevetti 0
selected - selezionate 0
volume - volumi 5.405
Totale 521.246


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.655 0 700 58 193 114 105 73 198 146 76 258 734
2022/20237.190 459 779 594 1.193 590 1.700 148 559 815 73 169 111
2023/20244.246 155 362 390 510 456 648 267 278 64 168 703 245
2024/202511.074 583 569 408 1.724 614 353 725 580 1.571 748 1.100 2.099
2025/202636.150 2.305 2.145 2.861 5.698 8.888 2.338 3.147 1.966 2.918 2.080 752 1.052
2026/2027923 714 209 0 0 0 0 0 0 0 0 0 0
Totale 74.956